GQG Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.39M | Sell |
25,158
-7,292,131
| -100% | -$1.7B | 0.01% | 75 |
|
|
2026
Q1 | $1.79B | Sell |
7,317,289
-434,977
| -6% | -$101M | 2.84% | 11 |
|
|
2025
Q4 | $1.6B | Buy |
7,752,266
+1,714,687
| +28% | +$339M | 2.64% | 13 |
|
|
2025
Q3 | $1.12B | Buy |
6,037,579
+5,988,242
| +12,137% | +$1.03B | 1.72% | 21 |
|
|
2025
Q2 | $7.54M | Buy |
49,337
+47,706
| +2,925% | +$7.33M | 0.01% | 68 |
|
|
2025
Q1 | $270K | Sell |
1,631
-4
| -0.2% | -$626 | ﹤0.01% | 82 |
|
|
2024
Q4 | $236K | Sell |
1,635
-1,501,005
| -100% | -$233M | ﹤0.01% | 92 |
|
|
2024
Q3 | $244M | Buy |
1,502,640
+1,446,772
| +2,590% | +$231M | 0.38% | 46 |
|
|
2024
Q2 | $8.17M | Buy |
+55,868
| New | +$8.31M | 0.01% | 51 |
|
|
2023
Q1 | – | Sell |
-51,523
| Closed | -$9.1M | – | 85 |
|
|
2022
Q4 | $9.1M | Sell |
51,523
-1,106,633
| -96% | -$191M | 0.02% | 58 |
|
|
2022
Q3 | $189M | Sell |
1,158,156
-5,411,568
| -82% | -$916M | 0.55% | 39 |
|
|
2022
Q2 | $1.17B | Buy |
6,569,724
+67,963
| +1% | +$12.1M | 2.86% | 14 |
|
|
2022
Q1 | $1.15B | Buy |
6,501,761
+2,547,378
| +64% | +$433M | 2.67% | 15 |
|
|
2021
Q4 | $676M | Buy |
3,954,383
+3,627,424
| +1,109% | +$594M | 1.68% | 21 |
|
|
2021
Q3 | $52.8M | Buy |
326,959
+320,422
| +4,902% | +$54.7M | 0.14% | 41 |
|
|
2021
Q2 | $1.08M | Sell |
6,537
-422,243
| -98% | -$69.9M | ﹤0.01% | 55 |
|
|
2021
Q1 | $70.5M | Buy |
428,780
+205,813
| +92% | +$33.3M | 0.26% | 46 |
|
|
2020
Q4 | $35.1M | Buy |
222,967
+212,249
| +1,980% | +$31.3M | 0.12% | 49 |
|
|
2020
Q3 | $1.59M | Buy |
10,718
+511
| +5% | +$75.6K | 0.01% | 60 |
|
|
2020
Q2 | $1.44M | Buy |
+10,207
| New | +$1.49M | 0.01% | 55 |
|
|
2018
Q3 | – | Sell |
-124,635
| Closed | -$13.1M | – | 53 |
|
|
2018
Q2 | $13.1M | Buy |
124,635
+121,464
| +3,830% | +$15.2M | 0.31% | 36 |
|
|
2018
Q1 | $406K | Sell |
3,171
-540,486
| -99% | -$73.1M | 0.01% | 48 |
|
|
2017
Q4 | $76M | Buy |
543,657
+20,825
| +4% | +$2.9M | 2.39% | 14 |
|
|
2017
Q3 | $68M | Buy |
522,832
+243,306
| +87% | +$32.3M | 2.39% | 16 |
|
|
2017
Q2 | $37M | Buy |
+279,526
| New | +$35.7M | 2.72% | 12 |
|
|
2017
Q1 | – | Sell |
-2,168
| Closed | -$250K | – | 50 |
|
|
2016
Q4 | $250K | Buy |
+2,168
| New | +$250K | 0.17% | 42 |
|
Other funds holding JNJ
GQG Partners's JNJ Position: Q2 2026 in Review
GQG Partners reduced its Johnson & Johnson (JNJ) stake by 100% in Q2 2026, selling an estimated $1.7B and leaving 25,158 shares worth $6.39M. The position accounts for 0.01% of the portfolio, ranked #75.
GQG Partners first reported a position in JNJ in Q4 2016 and has held it in 26 quarters since. The position peaked at $1.79B in Q1 2026. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- GQG Partners held 25,158 shares of Johnson & Johnson worth $6.39M as of Q2 2026.
- GQG Partners sold 7,292,131 Johnson & Johnson shares in Q2 2026, an estimated $1.7B.
- Johnson & Johnson made up 0.01% of GQG Partners's portfolio in Q2 2026, its #75 holding.
- GQG Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 26 quarters since.
- GQG Partners's Johnson & Johnson position peaked at $1.79B in Q1 2026.
- 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on GQG Partners's 13F filing for Q2 2026, filed 12 Aug 2026.